30th May 2007 17:10
AstraZeneca PLC30 May 2007 TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to whichvoting rights are attached: AstraZeneca PLC 2. Reason for the notification (place an X inside the appropriate bracket/s) An acquisition or disposal of voting rights: ( X ) An acquisition or disposal of financial instruments which may result in theacquisition of shares already issued to which voting rights are attached: ( ) An event changing the breakdown of voting rights: ( ) Other (please specify) : ( ) 3. Full name of person(s) subject to the notification obligation: AXA S.A, 25 Avenue Matignon, 75008 Paris and its group companies 4. Full name of shareholder(s) (if different from 3.) : ................. 5. Date of the transaction (and date on which the threshold is crossed orreached if different): 14 May 2007 6. Date on which issuer notified: 29 May 2007 7. Threshold(s) that is/are crossed or reached: 5% 8. Notified details: ................. A: Voting rights attached to shares Class/type of shares if possible Situation previous to the Triggering transactionusing the ISIN CODE Number of shares Number of voting Rights Ordinary Shares 74,550,675 74,550,675American Depositary Receipt - - Resulting situation after the triggering transaction Class/type of shares if Number of shares Number of voting rights % of voting rightspossible using the ISINCODE Direct Direct Indirect Direct Indirect Ordinary Shares 20,800,377 20,800,377 54,878,468 1.39 3.65American Depositary Receipt - - - - - B: Financial Instruments Resulting situation after the triggering transaction Type of Expiration Date Exercise/Conversion Number of voting rights % of voting rightsfinancial Period/ Date that may be acquired if theinstrument instrument is exercised/ converted. N/A Total (A+B)Number of voting rights % of voting rights75,678,845 5.04% 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: ................. Proxy Voting: 10. Name of the proxy holder: ................. 11. Number of voting rights proxy holder will cease to hold: ................. 12. Date on which proxy holder will cease to hold voting rights: ................. 13. Additional information: ................. 14. Contact name: Justin Hoskins - Assistant Secretary 15. Contact telephone number: 020 7304 5112 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Astrazeneca